BACKGROUND Pembrolizumab is a highly selective IgG4 kappa isotype monoclonal antibody against the programmed cell death-1(PD-1)molecule.In the treatment of nons
BACKGROUND Gut microbiota is an emerging field of research,with related research having breakthrough development in the past 15 years.Bibliometric analysis can